Skip to main content
S 948 108th Congress Senate

Drug Company Gift Disclosure Act

Official title: A bill to require prescription drug manufacturers, packers, and distributors to disclose certain gifts provided in connection with detailing, promotional, or o… Show full official titleShow less

Official title: A bill to require prescription drug manufacturers, packers, and distributors to disclose certain gifts provided in connection with detailing, promotional, or other marketing activities, and for other purposes.

Introduced: April 29, 2003 Introduced by: Schumer, Charles E. Democratic · New York See on congress.gov
Commerce Drug industryElectronic government informationFines (Penalties)Gifts
More subjectsShow fewer subjects
Government Operations and PoliticsGovernment paperworkGovernment publicityHealthHospitalsInternetLawMarketingNursing homesPharmaciesPharmacistsPhysiciansRebatesSales promotionScience, Technology, CommunicationsTrade secrets
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 29, 2003
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5494-5495)
Apr 29, 2003
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 29, 2003

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5494-5495)

 Plain-English summary Congressional Research Service
Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require drug manufacturers, packers, and distributors to disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made to covered health entities in connection with marketing activities; and (2) cash rebates, discounts, or any other financial consideration to any pharmaceutical benefit manager in connection with marketing activities. Makes such information available to the public, but retains the confidentiality of trade secrets. Establishes civil penalties for violations.
 Related & companion bills 1
  • HR 757 Identical bill Drug Company Gift Disclosure Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 948: Drug Company Gift Disclosure Act. 108th Congress. Open America. https://openamerica.io/bill/108-S-948/
MLA
"S. 948: Drug Company Gift Disclosure Act." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-S-948/.
Bluebook (legal)
S. 948, 108th Cong. (2026), https://openamerica.io/bill/108-S-948/.
Markdown link
[S. 948: Drug Company Gift Disclosure Act](https://openamerica.io/bill/108-S-948/)
Report a problem